2-((4-(1-[11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)-quinoline

ID: ALA1684440

PubChem CID: 51351520

Max Phase: Preclinical

Molecular Formula: C25H20N4O

Molecular Weight: 392.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  [11CH3]n1cc(-c2ccncc2)c(-c2ccc(OCc3ccc4ccccc4n3)cc2)n1

Standard InChI:  InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3/i1-1

Standard InChI Key:  AZEXWHKOMMASPA-BJUDXGSMSA-N

Molfile:  

     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    1.7827  -14.4468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4879  -14.8721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4731  -15.6976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7509  -16.0942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0436  -15.6694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3214  -16.0660    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3839  -15.6450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3690  -14.8194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3532  -14.4187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0605  -14.8475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2048  -14.4743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9166  -14.8886    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6290  -14.4712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6316  -13.6456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3477  -13.2382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0613  -13.6524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0567  -14.4745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3405  -14.8859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0342  -12.8347    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5202  -13.4808    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7481  -13.1975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7800  -12.3717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5751  -12.1479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4060  -10.6777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1054  -11.1119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0775  -11.9360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3502  -12.3259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6508  -11.8874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6797  -11.0661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8562  -12.8688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  1 10  1  0
  5 10  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 13 18  2  0
 12 13  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 19 23  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 24 29  2  0
 22 26  1  0
 19 30  1  0
 16 21  1  0
 11 12  1  0
  2 11  1  0
M  ISO  1  30  11
M  END

Associated Targets(non-human)

Cerebellum (218 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Striatum (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cortex (245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4256 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Testes (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Kidney (678 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Heart (1007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Muscle (343 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (4264 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lung (635 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Blood (1237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 392.46Molecular Weight (Monoisotopic): 392.1637AlogP: 5.28#Rotatable Bonds: 5
Polar Surface Area: 52.83Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.31CX LogP: 4.67CX LogD: 4.67
Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.41Np Likeness Score: -1.16

References

1. Tu Z, Fan J, Li S, Jones LA, Cui J, Padakanti PK, Xu J, Zeng D, Shoghi KI, Perlmutter JS, Mach RH..  (2011)  Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain.,  19  (5): [PMID:21315609] [10.1016/j.bmc.2011.01.032]
2. Sun J, Xiao Z, Haider A, Gebhard C, Xu H, Luo HB, Zhang HT, Josephson L, Wang L, Liang SH..  (2021)  Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery.,  64  (11.0): [PMID:34042442] [10.1021/acs.jmedchem.1c00115]

Source